The table below shows CAPRICOR THERAPEUTICS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
$2.26M
$3.97M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$27.38M
$20.36M
$22.05M
$18.92M
$11.81M
$12.50M
SG&A
CAPR annual revenue (10-K history)
CAPRICOR THERAPEUTICS, INC. reported annual revenue of $0.00 for fiscal year 2025. That is down 100.0% from $22.27M in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $4.00M (FY 2016) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.